drugset / Trial / NCT00016523

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

NCT00016523 ↗

RandomizedSingle-groupQuadruple-blindTreatment

Summary

This multicenter trial tested whether inhaled nitric oxide would reduce death or the need for oxygen in preterm infants (less than 34 weeks gestational age) with severe lung disease.

Timeline

Start
2001-01
Primary completion
2003-09
Completion
2006-05

Outcome

Missed primary endpoint

Stopped: “Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm”

paper The use of inhaled nitric oxide in critically ill premature infants weighing less than 1500 g does not decrease the rates of death or bronchopulmonary dysplasia. PMID 16000352 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 5 ppm Inhaled
Subject Nitric Oxide Other / unclassified 10 ppm Inhaled